Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells

PURPOSE: Tofacitinib is a pan-Janus kinase (JAK) inhibitor that suppresses cytokine signaling and in turn, the cells that participate in inflammatory immunopathogenic processes. We examined the capacity of tofacitinib to inhibit the induction of experimental autoimmune uveitis (EAU) and related immu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Vis
Päätekijät: Bing, So Jin, Lyu, Cancan, Xu, Biying, Wandu, Wambui S., Hinshaw, Samuel J., Furumoto, Yasuko, Caspi, Rachel R., Gadina, Massimo, Gery, Igal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Molecular Vision 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531779/
https://ncbi.nlm.nih.gov/pubmed/33088168
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia